Jorge Ishizawa

  • Citations Per Year
Learn More
Disease recurrence is the major problem in the treatment of acute myeloid leukemia (AML). Relapse is driven by leukemia stem cells, a chemoresistant subpopulation capable of re-establishing disease. Patients with p53 mutant AML are at an extremely high risk of relapse. B-cell-specific Moloney murine leukemia virus integration site 1 (BMI-1) is required for(More)
nizes that valuable understanding for the sustainable use and regeneration of natural systems resides in practices of societies rooted in local cultures and ecosystems. In compliance with the CBD, the Global Environmental Facility (GEF) has provided funds for establishing project interventions for in situ conservation of the diversity of native plants and(More)
  • 1